4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-021820
President, R&D sold 622 shares at $29.87 ($18,579)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-03-29 | Sale | −622 | $29.87 | $18,579 | 94,304 | D: show line 1 in the form |
| Open-market sales · 622 sh · avg $29.87 · $18,579 | |||||||
Loading xslF345X03/doc4.xml…